University of Maryland researchers to work on Radiation Nuclear Model Development program

University of Maryland School of Medicine researchers have won the contract for the Radiation Nuclear Model Development program.

Researchers at the University of Maryland School of Medicine will be working on the Radiation Nuclear Model Development program.

They were awarded the contract by the Biomedical Advanced Research and Development Authority, which is the department under the Office of the Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.

"Our division is in a unique position to lead in medical countermeasures research," Dr. Zeljko Vujaskovic, director of the department’s Division of Translational Radiation Science, said. "We have extensive experience with experimental models, 30,000 square feet of dedicated space for radiation research and collaborative expertise from across the broadest spectrum of countermeasure investigations, which allow us to rapidly configure and implement solutions-oriented approaches to even the most difficult challenges."

Vujaskovic will lead the project. The DTRS launched in 2012 when Vujaskovic joined the department from Duke University. The department partners with other government and medical teams.

"We are very excited to continue this critical research with BARDA," Dr. E. Albert Reece, vice president of medical affairs, said. "In particular, our ability to utilize our GLP-testing facility for medical countermeasures, oncology drugs based on tumor models and normal tissue complications from radiation treatment makes us a true leader in the field of translational radiation science."

Organizations in this story

University of Maryland School of Medicine 655 W Baltimore St Baltimore, MD 21201

Get notified the next time we write about University of Maryland School of Medicine!